We’re making breakthroughs to target rare and orphan diseases. This is our journey.
Life Science combination products
Fighting the war on rare and orphan diseases and cancers through developing combination products to challenge unmet medical diagnosis for patients
Molding a novel development of the first ever "liquid stent". This combination device is everything but a stent. Hyper-constructing a fluid compound that is as tough as steel and as superfluous as water. ---------->
Extracting elements from both Project Hyperion and Project Hercules, we're creating an intrinsic combination device to target pediatric DIPG (Diffuse Intrinsic Pontine Glioma). -------->
Our lead combination development candidate, Project Hercules incorporates many of the novel properties to regenerate natural elements of the hip -------------->
A unique approach to hemoglobin, protein and synthetic cell modification; this combination device is targeting a two pronged approach in the following:
Pantothenate Kinase-Associated Neurodegeneration (PKAN) to Amyotrophic Lateral Sclerosis (ALS)
Paroxysmal Nocturnal Hemoglobinuria (PNH) to Lewy Body Dementia
Life science news
To find out more about our combination products or to partner with us in the development stages, contact us below.